These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3555125)

  • 1. Early identification of renal problems in patients receiving chronic lithium treatment.
    Samiy AH; Rosnick PB
    Am J Psychiatry; 1987 May; 144(5):670-2. PubMed ID: 3555125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal glomerular function and long-term lithium therapy.
    Depaulo JR; Correa EI; Sapir DG
    Am J Psychiatry; 1981 Mar; 138(3):324-7. PubMed ID: 7468828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term lithium treatment and renal functions. A prospective study.
    Smigan L; Bucht G; von Knorring L; Perris C; Wahlin A
    Neuropsychobiology; 1984; 11(1):33-8. PubMed ID: 6738833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preprocedure and Postprocedure Predictive Values of Serum β2-Microglobulin for Contrast-Induced Nephropathy in Patients Undergoing Coronary Computed Tomography Angiography: A Comparison With Creatinine-Based Parameters and Cystatin C.
    Li S; Zheng Z; Tang X; Peng L; Luo Y; Dong R; Zhao Y; Liu J
    J Comput Assist Tomogr; 2015; 39(6):969-74. PubMed ID: 26248154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of glomerular filtration rate by serum creatinine and serum beta 2-microglobulin.
    Trollfors B; Norrby R
    Nephron; 1981; 28(4):196-9. PubMed ID: 6170902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes.
    Oddoze C; Morange S; Portugal H; Berland Y; Dussol B
    Am J Kidney Dis; 2001 Aug; 38(2):310-6. PubMed ID: 11479157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium-induced renal disease: a prospective study.
    Jorkasky DK; Amsterdam JD; Oler J; Braden G; Alvis R; Geheb M; Cox M
    Clin Nephrol; 1988 Dec; 30(6):293-302. PubMed ID: 3243040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum beta-2-microglobulin estimation as an indicator of the glomerular filtration rate.
    Jialal I; Nathoo BC; Bejai S; Joubert SM
    S Afr Med J; 1982 Jun; 61(25):953-4. PubMed ID: 6178173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationships among serum creatinine, beta 2-microglobulin and inulin clearance in renal disease.
    Shieh SD; Tschai HJ; Huang HW; Yu MD; Young TK; Chen WL
    Taiwan Yi Xue Hui Za Zhi; 1983 Dec; 82(12):1210-5. PubMed ID: 6371185
    [No Abstract]   [Full Text] [Related]  

  • 10. [Is the serum level of beta 2 microglobulin a better marker of glomerular filtration than blood creatinine?].
    François B; Assenat H; Cahen R; Bizollon C
    Nephrologie; 1982; 3(3):116-8. PubMed ID: 6183598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Usefulness of serum cystatin C for the diagnosis of impaired renal function].
    Oyabu C; Hayashi N; Sugiyama D; Umezu M; Mukai M; Kawano S; Kumagai S
    Rinsho Byori; 2006 Dec; 54(12):1204-8. PubMed ID: 17265892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prospective evaluation of renal function by serum cystatin-C: comparison with three other parameters of glomerular filtration rate].
    Tamba K; Kusano E; Ando Y; Asano Y
    Nihon Jinzo Gakkai Shi; 2001 Nov; 43(8):646-50. PubMed ID: 11808075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: 'Shrunken pore syndrome'.
    Grubb A; Lindström V; Jonsson M; Bäck SE; Åhlund T; Rippe B; Christensson A
    Scand J Clin Lab Invest; 2015 Jul; 75(4):333-40. PubMed ID: 25919022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Beta 2 microglobulin in the serum as a parameter of glomerular kidney function in the first days of life].
    Nolte S; Pringsheim W; Künzer W
    Monatsschr Kinderheilkd; 1986 Oct; 134(10):725-8. PubMed ID: 3540620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal function in patients receiving long-term lithium therapy.
    Uldall PR; Awad AG; McCormick WO; Carter LB; Gonsick T; Grass CL; Kugelmass MI
    Can Med Assoc J; 1981 Jun; 124(11):1471-4. PubMed ID: 7237329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum beta2-microglobulin concentration as a novel marker to distinguish levels of risk in acute heart failure patients.
    Kawai K; Kawashima S; Miyazaki T; Tajiri E; Mori M; Kitazaki K; Shirotani T; Inatome T; Yamabe H; Hirata K; Yokoyama M
    J Cardiol; 2010 Jan; 55(1):99-107. PubMed ID: 20122555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary excretion of albumin and retinol-binding protein in lithium-treated patients.
    Jensen HV; Holm J; Hemmingsen L; Thiesen S; Andersen J
    Acta Psychiatr Scand; 1988 Sep; 78(3):375-8. PubMed ID: 3057816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albumin and beta 2-microglobulin excretion in patients on long-term lithium treatment.
    Hansen HE; Mogensen CE; Sørensen JL; Nørgaard K; Heilskov J; Amdisen A
    Nephron; 1981; 29(5-6):229-32. PubMed ID: 6172717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of serum cystatin-C as a marker of the renal function: a comparative evaluation with beta 2-microglobulin, alpha 1-microglobulin and creatinine].
    Hotta O; Yusa N; Mukaiyama I; Taguma Y
    Nihon Jinzo Gakkai Shi; 1999 Dec; 41(8):797-803. PubMed ID: 10655728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross-sectional study of glomerular function in 740 unselected lithium patients.
    Kehoe RF
    Acta Psychiatr Scand; 1994 Jan; 89(1):68-71. PubMed ID: 8140909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.